Related Experiment Video
Updated: Aug 16, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Angioplasty for femoral artery occlusion: comparison with surgery
Insights
Percutaneous transluminal angioplasty is effective for short superficial femoral artery occlusions. It offers comparable patency to femoropopliteal bypass grafts for longer lesions when saphenous vein is unavailable.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Superficial femoral artery occlusions pose a significant challenge in peripheral artery disease management.
- Treatment options include angioplasty and femoropopliteal bypass grafting, each with distinct outcomes.
- Optimal treatment selection depends on lesion characteristics and available graft materials.
Purpose of the Study:
- To compare the efficacy and long-term patency of percutaneous transluminal angioplasty versus femoropopliteal bypass grafting for superficial femoral artery occlusions.
- To evaluate the impact of lesion length on angioplasty success and patency rates.
- To assess the performance of different bypass graft types in femoropopliteal reconstructions.
Main Methods:
- Retrospective analysis of 46 patients undergoing percutaneous transluminal angioplasty for superficial femoral artery occlusions (1-20 cm).
- Comparison with 133 patients who underwent femoropopliteal bypass grafting during the same period.
- Life table analysis used to determine 1- and 2-year patency rates for both treatment groups.
Main Results:
- Percutaneous transluminal angioplasty achieved a primary success rate of 76% with a 1-year patency of 56.8%.
- Angioplasty success was significantly influenced by lesion length, with better outcomes for shorter occlusions (4 cm).
- Femoropopliteal bypass grafts showed a 1-year patency of 60.2% and 2-year patency of 42.1%, with poorer performance noted for non-saphenous vein grafts.
Conclusions:
- Percutaneous transluminal angioplasty is the preferred treatment for short superficial femoral artery occlusions.
- For longer occlusions, angioplasty is a viable option when saphenous vein grafts are not utilized.
- Treatment choice should consider lesion length and the availability of autologous saphenous vein for bypass procedures.
Abstract:
Forty-six patients with superficial femoral artery occlusions (range, 1-20 cm) had percutaneous transluminal angioplasty. The primary success rate was 76% with a late closure in six patients. Life table analysis showed a 1 year patency of 56.8%, maintained at 2 years among the group in whom the successful was 4 cm, while in those in whom the lesion was not crossed, it was 9 cm. Over the same period, 133 femoropopliteal bypass grafts were performed. The patients were comparable as to runoff, incidence of diabetes, and distal ischemia. The 1 year patency was 60.2% and the 2 year patency, 42.1%, largely because of the poor performance of grafts other than saphenous vein. Angioplasty seems to be the treatment of choice for short segment occlusions, and should be used in longer occlusions if saphenous vein is not going to be used.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm III: Interprofessional Care

